(Q40837848)

24 September 2017

title

Phase I evaluation of peplomycin with special reference to pulmonary toxicity (English)

1 reference

24 September 2017

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90128-1

24 August 2023

author name string

P. G. Sørensen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6190655

24 August 2023

M. Rørth

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6190655

24 August 2023

H. H. Hansen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6190655

24 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6190655

24 August 2023

publication date

1 March 1983

1 reference

full work available at URL

24 September 2017

https://api.elsevier.com/content/article/PII:0277537983901281?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90128-1

https://api.elsevier.com/content/article/PII:0277537983901281?httpAccept=text/plain

24 August 2023

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90128-1

European Journal of Cancer & Clinical Oncology

24 August 2023

published in

1 reference

24 September 2017

volume

19

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

319-325

1 reference

Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma

24 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90128-1

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

24 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90128-1

Phase II evaluation of bleomycin.A Southwest Oncology Group study

24 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90128-1

Relative pulmonary toxicity and antitumor effects of two new bleomycin analogs, pepleomycin and tallysomycin A

24 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90128-1

A Review of Clinical Studies of Pepleomycin

24 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90128-1

A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide

24 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90128-1

Large-dose bleomycin therapy and pulmonary toxicity. A possible role of prior radiotherapy

24 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90128-1

Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients

24 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90128-1

24 August 2023

Identifiers

1 reference

24 September 2017

1 reference